{
    "nct_id": "NCT06744712",
    "official_title": "Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients",
    "inclusion_criteria": "1. Written informed consent and HIPAA authorization for release of personal health information, and assent when applicable, from the participant, parent or legal guardian.\n2. Age â‰¤ 26 years at the time of consent.\n3. Newly diagnosed with a malignancy and planning to undergo anti-cancer therapy; or bone marrow transplant candidate with a non-malignant diagnosis who has not yet undergone myeloablative conditioning regimen.\nHealthy volunteers allowed\nMust have maximum age of 26 Years",
    "exclusion_criteria": "1. Anti-cancer therapy has already been initiated. Note: Enrollment after initiation of intrathecal chemotherapy will be allowed.\n2. Previously received bone marrow transplant or planning to receive as part of initial upfront therapy for a malignant condition.\n3. Prior history of tissue or organ transplant.",
    "miscellaneous_criteria": ""
}